A LinkedIn post from Innovaccer highlights coverage in Healthcare IT News describing how Kettering Health restructured post-implant heart failure care using Innovaccer’s technology. The post cites reported outcomes including a 77% reduction in clinician time, diuretic adjustment time cut from 7.5 minutes to 90 seconds, and a 7.5-point increase in pressure control at nine months, all within the existing EHR environment.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The post also notes commentary from Jody Underwood, Vice President of Population Health at Kettering Health, emphasizing the importance of operational models alongside clinical approaches. For investors, these reported efficiency and clinical metrics may suggest growing validation of Innovaccer’s platform in complex cardiovascular care workflows and its ability to integrate without adding new systems, which could support adoption and stickiness among health systems.
In addition, the post references that Innovaccer has been accepted into the first cohort of the Centers for Medicare & Medicaid Services (CMS) ACCESS Model, targeted to launch in July 2026. Participation in this value-based care initiative could position the company to expand its role in federally aligned care-delivery programs, potentially enhancing long-term revenue opportunities tied to outcomes-based contracts and population health management.
More broadly, the association with a named health system and national policy initiatives may strengthen Innovaccer’s competitive profile in the healthcare IT and population health segments. If such reported results are replicated across additional clients, the company could benefit from increased credibility with providers seeking to reduce clinician burden and improve chronic disease management within existing EHR infrastructures.